1 / 4

Understanding Impact of COVID-19 on Neurological Conditions via RWE

A pharmaceutical company requested to conduct research for Long COVID outcomes using RWD to evaluate their productu2019s indication for treating neurological conditions for Long COVID. The aim was to understand COVID-19's impact on neurodegenerative conditions and identify biomarkers predicting Long COVID-associated neurodegenerative conditions.

Healthark
Download Presentation

Understanding Impact of COVID-19 on Neurological Conditions via RWE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CASE STUDY Understanding Impact of COVID-19 on Neurological Conditions via RWD

  2. A pharmaceutical company requested to conduct research for Long COVID outcomes using RWD to evaluate their product’s indication for treating neurological conditions for Long COVID. The aim was to understand COVID-19's impact on neurodegenerative conditions and identify biomarkers predicting Long COVID-associated neurodegenerative conditions. THE CHALLENGE

  3. HEALTHARK’S ROLE Analyzed Incidence of Long COVID Conditions Healthark assisted the client in analyzing the retrospective Real-World Data (RWD) using an open-source dataset to assess the incidence of Long COVID-related neurological conditions among patients who tested positive for COVID-19. Literature Review & Preliminary Research Cohort Foundation Analysis Execution

  4. Over a six-month period, Healthark developed a framework of parameters for identifying potential biomarkers related to Long COVID. IMPACT

More Related